6. CLINICAL STUDIES
Non-serious events due to the use of SafeR 2 (AAI <> DDD) included: delay in switching on
2nd degree AV block, inappropriate classification of a PAC, disagreement between markers
and recorded EGM, atrial pacing above the maximum rate, recycling on an R-wave in a
refractory period, and disagreement in the statistics for switches to DDD. No patient
symptoms were associated with these events.
SORIN – INTENSIA DR 154 – U152A
21
Содержание Intensia DR 154
Страница 1: ...Implant manual Implantable cardioverter defibrillator DR model 154...
Страница 2: ...blank...
Страница 3: ......
Страница 4: ...blank...